ReviewFrontiers in chemistry2025
Exploring imaged capillary isoelectric focusing parameters for enhanced charge variants quality control.
Review in Frontiers in chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Impact of Amino Acid Excipients on icIEF Method Development in Protein Therapeutics: A Formulation-Aware Analytical Framework.AAPS PharmSciTech · 2026Article
- Biopharmaceutical analysis - current analytical challenges, limitations, and perspectives.Analytical and bioanalytical chemistry · 2026Review
- A Design of Experiments and Risk Management-Driven Analytical Platform for Charge Variant Analysis of Therapeutic Antibodies by Imaged Capillary Isoelectric Focusing.The AAPS journal · 2025Article
- Article
- Evaluation of Methods Employed in Establishing Preclinical Similarity of Adalimumab Biosimilars.Advances in pharmacological and pharmaceutical sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biopharmaceuticals are increasingly utilised in the treatment of oncological, inflammatory, and autoimmune diseases, largely due to their exceptional specificity in targeting antigens. However, their structural complexity, heterogeneity, and sensitivity pose crucial challenges in their production, purification, and delivery. Charge heterogeneity analysis, a Critical Quality Attribute of these biomolecules used in their Quality Control, is often performed using separative analytical techniques such as imaged capillary Isoelectric Focusing (icIEF). Recognized as a gold standard by the industry, icIEF leverages a pH gradient to provide high-resolution profiling of charge variants in biotherapeutics. In this review, critical experimental parameters for icIEF method development in the context of biotherapeutic drug development and QC will be discussed. Key aspects, including sample preparation, capillary properties, carrier ampholytes, stabilizers, and detection are examined, and supported by recent literature. Advances in icIEF technology and its expanding applications underline its robustness, reproducibility, and compliance with regulatory standards, affirming its pivotal role in ensuring the identity and consistency of biological products.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.